Literature DB >> 22802576

Tonsillectomy and IgA nephritis.

Claudio Ponticelli1.   

Abstract

IgA nephritis (IgAN) is an autoimmune disease characterized by deposits of IgA in the glomerular mesangium. Clinically, the disease may be punctuated by episodes of macroscopic haematuria often associated with pharingotonsillitis or may be oligosyntomatic with microscopic haematuria and mild proteinuria. The natural course of IgAN may be indolent and benign; however, some 30-50% of patients may progress to end-stage renal disease when follow-up is extended to ≥20 years. In patients with IgAN, circulating IgA1 molecules have an aberrant structure of O-glycans in the hinge region, which is characterized by abbreviated glycans composed of N-acetylgalactosamine, with or without sialic acid. These aberrant IgA1 trigger the production of autoantibodies, with formation of immune complexes that deposit in the mesangium causing inflammation and production of extracellular matrix. A number of experimental and clinical data outlined a possible pathogenetic role of tonsillitis. As a consequence, tonsillectomy has been frequently performed in Japan. Observational studies, made in patients with normal renal function and mild proteinuria, reported that tonsillectomy could reduce the episodes of macrohaematuria as well as the entity of microhaematuria and proteinuria. However, the available studies had short-term follow-up and could not asses the role of tonsillectomy in protecting from renal function deterioration. In a longitudinal retrospective study, Isseki et al. compared the outcome of tonsillectomized patients with IgAN with that of IgAN patients who did not receive tonsillectomy. Tonsillectomized patients had a higher number of remissions and a better slope of glomerular filtration rate in comparison with controls. These data are interesting and suggest that tonsillectomy may prevent renal dysfunction in patients with IgAN and normal renal function. However, the retrospective nature of the study and the presence of some confounding factors require further investigations to confirm these promising data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802576     DOI: 10.1093/ndt/gfs093

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Authors:  Jing Xue; Li-Ping Zhu; Qiang Wei
Journal:  Glycoconj J       Date:  2013-06-20       Impact factor: 2.916

2.  Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients.

Authors:  Tibor Kovács; Tibor Vas; Csaba P Kövesdy; Péter Degrell; Györgyi Nagy; Zsuzsanna Rékási; István Wittmann; Judit Nagy
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

3.  Impact of tonsillectomy combined with steroid pulse therapy on immunoglobulin A nephropathy depending on histological classification: a multicenter study.

Authors:  Tetsu Miyamoto; Tomoya Nishino; Takashi Nakata; Yuji Sato; Hiroyuki Komatsu; Tadashi Uramatsu; Nana Ishimatsu; Kaede Ishida; Ryota Serino; Yutaka Otsuji; Masanobu Miyazaki; Tadashi Tomo; Masahito Tamura; Shouichi Fujimoto
Journal:  Clin Exp Nephrol       Date:  2015-06-09       Impact factor: 2.801

Review 4.  The role of tonsillectomy in IgA nephropathy.

Authors:  Sandro Feriozzi; Rosaria Polci
Journal:  J Nephrol       Date:  2015-11-18       Impact factor: 3.902

5.  Study of tonsillectomy for IgA nephropathy patients: short- and longer-term observation.

Authors:  Yuyuan Liu; Hong Liu; Xiwen Tu; Youming Peng; Fuyou Liu; Fan Zhang; Chunyan Guo; Yang Liu; Xinming Yang; Guochun Chen; Yinghong Liu; Fang Yuan
Journal:  Int Urol Nephrol       Date:  2013-11-23       Impact factor: 2.370

6.  The Relationship between the Efficacy of Tonsillectomy and Renal Pathology in the Patients with IgA Nephropathy.

Authors:  Tsutomu Nomura; Yoshimi Makizumi; Tsuyoshi Yoshida; Tatsuya Yamasoba
Journal:  Int J Otolaryngol       Date:  2014-05-19

7.  Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy.

Authors:  Huining Li; Dan Kong; Yangyang Xu; Xiaomei Li; Guodong Yao; Kexin Chen; Qi You; Qingtao Shi; Lei Zhang; Xin Wang; Dawei Yuan; Shusheng Miao; Jingshu Geng; Xiaoming Jin; Hongxue Meng
Journal:  Oncotarget       Date:  2017-11-20

Review 8.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.

Authors:  Sheng Chang; Xiao-Kang Li
Journal:  Front Med (Lausanne)       Date:  2020-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.